# Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

> **NCT07551570** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jiangsu vcare pharmaceutical technology co., LTD** · enrollment: 32 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** VC005 Tablets

## Key facts

- **NCT ID:** NCT07551570
- **Lead sponsor:** Jiangsu vcare pharmaceutical technology co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07551570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07551570, "Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07551570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*